Biomarker analysis of patients with MET Delta ex14 mutated non small-cell lung cancer (NSCLC) treated with capmatinib in the GEOMETRY mono-1 study

MOLECULAR CANCER THERAPEUTICS(2019)

引用 3|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要